Evidence map›Paper›PMID 35323034›Full record

ArticleMicrobiology spectrum2022

Co-Occurrence of Rare ArmA-, RmtB-, and KPC-2-Encoding Multidrug-Resistant Plasmids and Hypervirulence

Ying Zhou, Wenxiu Ai, Yinjuan Guo, Xiaocui Wu, Bingjie Wang, YanLei Xu, Lulin Rao, Huilin Zhao, Xinyi Wang, Fangyou Yu

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Coexistence of blaBMC microbiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Comprehensive Genomic Analysis ofMicroorganisms · 2025
    Article
  6. Article
  7. Emergence and dissemination of multidrug-resistantFrontiers in cellular and infection microbiology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Characterization of ST15-KL112Infection and drug resistance · 2024
    Article
  14. Ribosome-targeting antibiotics and resistanceRSC medicinal chemistry · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Tandem Repeat ofInfection and drug resistance · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ying ZhouDepartment of Clinical Laboratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Wenxiu AiDepartment of Respiratory Medicine, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.
Yinjuan GuoDepartment of Clinical Laboratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Xiaocui WuDepartment of Clinical Laboratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Bingjie WangDepartment of Clinical Laboratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
YanLei XuDepartment of Clinical Laboratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Lulin RaoDepartment of Clinical Laboratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Huilin ZhaoDepartment of Clinical Laboratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Xinyi WangDepartment of Clinical Laboratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
Fangyou YuDepartment of Clinical Laboratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.ORCID 0000-0003-4924-2484
Tongji University · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) and the comparatively limited development of new antibiotics pose a major threat to public health. Aminoglycosides are important options that can lower the mortality rate effectively in combination therapy with β-lactam agents. However, in this study, we observed two multidrug-resistant (MDR) K. pneumoniae named 1632 and 1864 that exhibited high-level resistance to both carbapenems and aminoglycosides. Through whole-genome sequencing (WGS), the unusual co-occurrence of

Indexed as

Escherichia coli ProteinsKlebsiella InfectionsAminoglycosidesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsEscherichia coliHumansKlebsiella pneumoniaeMethyltransferasesMicrobial Sensitivity TestsOperonPlasmidsAminoglycosidesAnti-Bacterial AgentsArmA protein, E coliBacterial Proteinsbeta-LactamasesCarbapenemsEscherichia coli ProteinsMethyltransferasesRmtB protein, E coliarmAblaKCP-2iuc operonK. pneumoniaeplasmidrmtB

Identifiers

PMID35323034
PMCPMC9045180
OpenAlexW4220877474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.